Rating History for Cadrenal Therapeutics (CVKD) by Noble Capital
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 12/18/2023 | Robert LeBoyer | New Coverage | Outperform (N/A) |
4.00 (N/A) |
0.51 (1.97) |
286.27% | Details |
